fluorodeoxyglucose f18 has been researched along with Bewilderment in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fanale, CM; Melrose, RJ; Sultzer, DL; Veliz, JV; Weissberger, GH | 1 |
Dombernowsky, NW; Hasselbalch, SG; Law, I | 1 |
Chiou, SM; Hsu, YT; Huang, HY; Kao, CH; Tsai, CH; Tsai, MC; Wu, YC | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Bewilderment
Article | Year |
---|---|
Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Confusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2017 |
[Confusion, loss of consciousness and unspecific visual hallucinations may be symptoms of dementia with Lewy bodies].
Topics: Aged, 80 and over; Confusion; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Body Disease; Positron-Emission Tomography; Unconsciousness | 2018 |
Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient with Parkinson's disease after deep brain stimulation.
Topics: Confusion; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyridines; Subthalamus; Zolpidem | 2012 |